KD Logo

A company insider recently sold 12,000 shares of Enliven Therapeutics Inc [ELVN]. Should You Sale?

CHWY Stock

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Enliven Therapeutics Inc shares valued at $274,736 were sold by Lyssikatos Joseph P on Jul 01 ’24. At $22.89 per share, Lyssikatos Joseph P sold 12,000 shares. The insider’s holdings dropped to 1,105,035 shares worth approximately $23.81 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Also, Hohl Benjamin sold 4,250 shares, netting a total of over 95,922 in proceeds. Following the sale of shares at $22.57 each, the insider now holds 0 shares.

Before that, Kintz Samuel had sold 12,000 shares from its account. In a trade valued at $259,902, the PRESIDENT AND CEO traded Enliven Therapeutics Inc shares for $21.66 each. Upon closing the transaction, the insider’s holdings decreased to 12,000 shares, worth approximately $23.18 million.

As published in their initiating research note from Robert W. Baird on June 11, 2024, Enliven Therapeutics Inc [ELVN] has been an Outperform and the price target has been revised to $32. Analysts at Mizuho started covering the stock with ‘”a Buy”‘ outlook in a report released in early April. As of March 29, 2023, Jefferies has initiated its “Buy” rating for ELVN.

Analyzing ELVN Stock Performance

During the last five days, there has been a surge of approximately 1.75%. Over the course of the year, Enliven Therapeutics Inc shares have jumped approximately 55.71%. Shares of the company reached a 52-week high of $26.00 on 04/11/24 and a 52-week low of $10.90 on 03/15/24. A 50-day SMA is recorded $21.74, while a 200-day SMA reached $16.19. Nevertheless, trading volume fell to 0.14 million shares from 0.35 million shares the previous day.

Support And Resistance Levels for Enliven Therapeutics Inc (ELVN)

According to the 24-hour chart, there is a support level at 20.61, which, if violated, would cause prices to drop to 19.67. In the upper region, resistance lies at 22.51. The next price resistance is at 23.48. RSI (Relative Strength Index) is 48.20 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.16, which suggests the price will decrease in the coming days. Percent R is at 61.70%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.

Most Popular